Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 2Terminated 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 65Gastrointestinal 14Breast 11Thoracic 8Genitourinary 7Head & Neck 5Sarcoma 4Other solid neoplasm 4Dermatologic 4CNS 2Other hematologic neoplasm 1NET 1Myeloid 1Lymphoid 1Endocrine 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 38Anemia, Refractory, with Excess of Blasts 31Venous Thromboembolism 24Myelodysplastic Syndromes 21Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Leukemia 14Anemia, Aplastic 14Thrombocytopenia 10Lymphoma, Non-Hodgkin 10Lymphoma 10Leukemia, Myelomonocytic, Chronic 10Myeloproliferative Disorders 9Anemia 9Venous Thrombosis 8Primary Myelofibrosis 8Multiple Myeloma 8Hodgkin Disease 8Hematologic Neoplasms 8Cytopenia 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Febrile Neutropenia 7Congenital Bone Marrow Failure Syndromes 7Anemia, Sickle Cell 7Pulmonary Embolism 6Leukemia, Lymphocytic, Chronic, B-Cell 6Leukemia, Biphenotypic, Acute 6Fanconi Anemia 6Bone Marrow Failure Disorders 6Immunologic Deficiency Syndromes 5

Interventions

SLC25A33 protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Ovarian Epithelial × Classical hematology × Clear all
NCT06785077 2025-01-20

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

European Institute of Oncology

Phase NA Recruiting
157 enrolled
Classical hematologyGynecologicOther hematologic neoplasm

Carcinoma, Ovarian Epithelial, Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡